Switch to Ellen Wasan's research page...

2006

1. Cogswell S, Berger S, Waterhouse D, Bally MB, Wasan EK. A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model. Pharm Res. 23(11):2575-85. Epub 2006 Sep 13. (2006).
    [View Abstract - PubMed 17086505]  Request Paper

2005

2. Chiu GN, Abraham SA, Ickenstein LM, Ng R, Karlsson G, Edwards K, Wasan EK, Bally MB. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. J Control Release. 104(2):271-88. Epub 2005 Apr 13. (2005).
    [View Abstract - PubMed 15907579]  Request Paper

2002

3. Wasan EK, Waterhouse D, Sivak O, Bally MB, Klasa RJ, Wasan KM. Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells. Int J Pharm. 241(1):57-64. (2002).
    [View Abstract - PubMed 12086721]  Request Paper

1999

4. Bally MB, Harvie P, Wong FM, Kong S, Wasan EK, Reimer DL. Biological barriers to cellular delivery of lipid-based DNA carriers. Adv Drug Deliv Rev. 38(3):291-315. (1999).
    [View Abstract - PubMed 10837762]  Request Paper

5. Reimer DL, Kong S, Monck M, Wyles J, Tam P, Wasan EK, Bally MB. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates. J Pharmacol Exp Ther. 289(2):807-15. (1999).
    [View Abstract - PubMed 10215656]  Request Paper

6. Wasan EK, Harvie P, Edwards K, Karlsson G, Bally MB. A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection. Biochim Biophys Acta. 1461(1):27-46. (1999).
    [View Abstract - PubMed 10556486]  Request Paper

1998

7. Wasan EK, Fairchild A, Bally MB. Cationic liposome--plasmid DNA complexes used for gene transfer retain a significant trapped volume. J Pharm Sci. 87(1):9-14. (1998).
    [View Abstract - PubMed 9452961]  Request Paper

1996

8. Liu L, Lee K, Wasan EK, Gerson SL. Differential Sensitivity of Human and Mouse Alkyltransferase to O6-Benzylguanine Using a Transgenic Model Cancer Research 56:1880-1885 (1996).
    Request Paper

9. Wasan EK, Reimer DL, Bally MB. Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. J Pharm Sci. 85(4):427-33. (1996).
    [View Abstract - PubMed 8901083]  Request Paper

2005

1. Wasan EK, Gleave M, Fang K, Chi K, Bebb G, Edwards L and Bally MB. Docetaxel for Metastatic Cancer and Its Role in Combination Therapies for Advanced Prostate Cancer in Bone Metastasis, Drug Discovery and Development, Rabbani S, Singh G., eds., Humana Press. (2005).
    Request Paper

2. Wasan, EK, Zastre J. The Pharmacology of Combination Drug Therapy for Breast Cancer: Rationale for Developing Molecularly Targeted or Biologic Agents in Combination with Cytotoxic Drugs Development and Assessment of Fixed Dosed Drug Combinations for Use in the Treatment of Aggressive Cancers, Waterhouse D, Gelmon K, Klasa R, Chi K, Huntsman D, Ramsay E, Wasan, E, Zastre J, Edwards L, Tucker C, Zhang YZ, Yapp D, Dragowska V, Bally B. Current Drug Targets. (2005).
    Request Paper

1999

3. Wasan EK, Reimer DL, Harvie P, Wong FMP, Kong S, Bally MB. A Guide for the Preparation and Evaluation of Targeted Gene Delivery Systems Drug Targeting: Strategies, Principles and Applications. Methods in Molecular Medicine Vol. 25. Francis, GE and Delgado C, eds., Humana Press, Totowa, NJ. pp 255-304. (1999).
    Request Paper